We are committed to collaboration to drive progress, share knowledge and foster innovation. The challenges posed by intricate diseases demand a collective effort, thus we actively seek partnerships to explore synergies in collaborative project, compound licensing, software consulting etc. Together, we aim to amplify the impact of AI-driven drug discovery.